Navigation Links
Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew

INDIANAPOLIS, July 23, 2015 /PRNewswire/ -- To emphasize the importance of a support system in diabetes management, Lilly Diabetes and NASCAR XFINITY Series driver Ryan Reed will kick off the My Diabetes Pit Crew Sweepstakes today in association with the Lilly Diabetes 250, the NASCAR XFINITY Series race in Indianapolis. The sweepstakes hopes to encourage people with diabetes to acknowledge the people who have supported them throughout their diabetes journey.

A total of 24 entrants will be chosen at random to be honorary members of Reed's pit crew during the three NASCAR XFINITY Series races in November, which is American Diabetes Month. Eight people will be chosen for each race. Winners will have the option to have their names displayed on the fire suit worn by a member of Reed's racing pit crew and their pictures to appear in a mosaic on Reed's pit wall. Winners will receive educational materials from Lilly to help them manage their diabetes, along with a congratulatory phone call from Reed. Following the November races, winners will receive their personalized fire suit patch signed by Reed.

"The My Diabetes Pit Crew Sweepstakes not only positions winners as role models, it gets all people with diabetes thinking about what they can do to better manage their disease," said Kevin Cammack, senior marketing director, U.S., Lilly Diabetes. "Through the sweepstakes, we hope people with diabetes will think about the importance of a strong support system in the overall management of their diabetes."

To enter the My Diabetes Pit Crew Sweepstakes, people with diabetes can fill out an online entry form on the Drive to Stop Diabetes℠ website before September 18, 2015, at 11:59 p.m. ET.  The sweepstakes is open to all legal U.S. residents age 18 years (at least 19 in AL and NE and 21 in MS) or older with type 1 or type 2 diabetes (some state limitations may apply). Winners will be notified on or about October 1, 2015.

Since his diagnosis, Reed has joined forces with Lilly Diabetes and the American Diabetes Association on Drive to Stop Diabetes℠, an initiative that encourages people to take action to understand their risk for diabetes or, if they have diabetes, work with their doctor to manage it. Through Reed's example, children and adults with diabetes can see that the disease doesn't have to stand in the way of achieving their goals.

"Diabetes is a tough diagnosis, but with the right support system, you can properly manage the disease and continue to pursue your dreams," explains Reed. "My team members, family and doctor have been instrumental in helping me manage my diabetes."

The My Diabetes Pit Crew Sweepstakes builds on the success of the My Diabetes Pit Crew video series, which featured the people who support Reed on the track (his NASCAR pit crew) and off the track (his diabetes pit crew) and the role each plays in maintaining his car and his health.

For more information on the My Diabetes Pit Crew Sweepstakes or Drive to Stop Diabetes℠, visit, follow it on Twitter at @D2SDiabetes, follow Reed on Twitter at @driverRyanReed, like him on Facebook or follow Lilly Diabetes on Twitter at @LillyDiabetes.

NO PURCHASE NECESSARY.  The "My Diabetes Pit Crew Sweepstakes" is subject in all respects to the complete Official Rules available at Open only to entrants who, as of the entry date, are residents of the 50 U.S.A. and D.C. who are at least 18 years old (at least 19 in AL and NE and 21 in MS) and have been diagnosed with diabetes by a healthcare professional.  Void outside the eligible sweepstakes territory, and where prohibited or restricted by law.  Entry period begins at 10:00 a.m. ET on 7/23/15 and ends at 11:59 p.m. ET on 9/18/15.  LIMIT: 1 entry per person.  Entry method, limits, instructions, prize information, requirements and restrictions are set forth in the Official Rules.  Sponsor: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285.  Sweepstakes is not sponsored, endorsed or administered by or associated with NASCAR.

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit or follow us on Twitter: @LillyDiabetes.

About Eli Lilly and Company (NYSE: LLY)

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and P-LLY

LD95920 07/2015 ©Lilly USA, LLC 2015. All rights reserved.

Refer to: Julie Williams; (317) 627-4056;


Photo - 
Logo -

SOURCE Eli Lilly and Company
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance
2. Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center
3. Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
4. Lilly Statement on FDA Advisory Committee Review of Necitumumab
5. Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement
6. Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma
7. Lillys investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study
8. Lilly and Dana-Farber Cancer Institute Announce Research Collaboration
9. Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy
10. Lilly Declares Third-Quarter 2015 Dividend
11. Lilly Announces Webcast to Discuss Ixekizumab Phase III Data
Post Your Comments:
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted ... suffering in embittered divorce battles make better decisions and become truly child focused. This ... a bully, be resilient, and STOP the cycle! Don’t be a divorce bully!” (published ...
(Date:10/11/2019)... , ... October 11, 2019 , ... ... starting October 13, 2019, to recognize the dedication, compassion and quality patient outcomes ... collaborative process, providing a unique and vital link between patients, providers and payers ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once again ... reproductive medicine, with six abstracts accepted for poster presentations at the ASRM 2019 ... 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in the ...
Breaking Medicine Technology:
(Date:10/15/2019)... ... October 14, 2019 , ... Khalieghya Dandie-Evans, a liver transplant ... atop the Donate Life Rose Parade® float in the 131st Rose Parade® on New ... donation across Northern California and Northern Nevada, the organization’s service area. , Khalieghya, 17, ...
(Date:10/15/2019)... ... , ... Genomenon® announced today at the American Society of Human ... the Mastermind® Genomic Search Engine into the SOPHiA Platform and the ... of clinical researchers performing genomic analysis worldwide. , The SOPHiA Platform is ...
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of ... Construction. The event celebrated reaching the final height of the structure set to open ... its kind in Texas, STA’s facility will be home to an organ recovery center ...
(Date:10/10/2019)... ... 10, 2019 , ... In attendance at this year’s ISSN ... the significant results of an independent study presented by researchers from the University ... poster entitled “The Acute Effects of Citrulline Malate and Bonded Arginine Silicate Supplementation ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... recently acquired a majority interest in Advanced Fertility Care (AFC), an advanced reproductive ... joining forces to expand the availability of RE services to expectant families throughout ...
Breaking Medicine News(10 mins):